<p>Multiple myeloma (MM) is a plasma cell (PC) malignancy characterized by cytogenetic abnormalities, such as t(11;14)(q13;q32), resulting in <a href="https://www.ncbi.nlm.nih.gov/gene/595">CCND1</a> overexpression. The rs9344 G allele within CCND1 is the most significant susceptibility allele for t(11;14). We have found the G risk allele is enriched in both healthy individuals of African ancestry and African American individuals with MM. The overall aim of this study was to identify the mechanism behind why the G allele is enriched in t(11;14) MM. To reach this goal, we performed ATAC-seq from 100,000 <a href="https://www.ncbi.nlm.nih.gov/gene/6382">CD138</a>+ tumor cells from 26 patients with MM. In addition, we performed ChIP-seq using antibodies against H3K4me1, H3K27ac and H3K4me3 from 100,000 CD138+ tumor cells from 8 patients with MM. We used these data to evaluate whether the G allele of rs9344 is associated with elevated chromatin accessibility, H3K27ac and H3K4me3 in t(11;14) MM.</p>

Functional Variant rs9344 at 11q13.3 Regulates CCND1 Expression in    Multiple Myeloma with t(11;14)

Multiple Myeloma study with ATAC-seq, ChIP-Seq data on dbGaP (26 participants)

Functional Variant rs9344 at 11q13.3 Regulates CCND1 Expression in Multiple Myeloma with t(11;14)

Description

Applying For Access

Summary